CNBC's Jim Cramer on Friday walked investors through another busy week in the thick of earnings season. He highlighted reports from tech titans Apple, Amazon, Microsoft and Meta as well as the release ...

Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

Sunscreen use is crucial for protecting children from harmful UV radiation, but experts stress the importance of also using ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...